SK154299A3 - N-triazolyl-2-indolecarboxamides and their use as cck-a agonists - Google Patents
N-triazolyl-2-indolecarboxamides and their use as cck-a agonists Download PDFInfo
- Publication number
- SK154299A3 SK154299A3 SK1542-99A SK154299A SK154299A3 SK 154299 A3 SK154299 A3 SK 154299A3 SK 154299 A SK154299 A SK 154299A SK 154299 A3 SK154299 A3 SK 154299A3
- Authority
- SK
- Slovakia
- Prior art keywords
- och
- formula
- group
- compound
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9705850A FR2763337B1 (fr) | 1997-05-13 | 1997-05-13 | Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant |
PCT/FR1998/000905 WO1998051686A1 (fr) | 1997-05-13 | 1998-05-06 | N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a |
Publications (1)
Publication Number | Publication Date |
---|---|
SK154299A3 true SK154299A3 (en) | 2000-05-16 |
Family
ID=9506830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1542-99A SK154299A3 (en) | 1997-05-13 | 1998-05-06 | N-triazolyl-2-indolecarboxamides and their use as cck-a agonists |
Country Status (35)
Country | Link |
---|---|
EP (1) | EP0984960B1 (ru) |
JP (1) | JP2001524980A (ru) |
KR (1) | KR20010012541A (ru) |
CN (1) | CN1263528A (ru) |
AR (1) | AR011729A1 (ru) |
AT (1) | ATE232207T1 (ru) |
AU (1) | AU725530B2 (ru) |
BR (1) | BR9811465A (ru) |
CA (1) | CA2289573A1 (ru) |
CO (1) | CO4940485A1 (ru) |
CZ (1) | CZ289484B6 (ru) |
DE (1) | DE69811223T2 (ru) |
DK (1) | DK0984960T3 (ru) |
DZ (1) | DZ2486A1 (ru) |
EE (1) | EE9900524A (ru) |
ES (1) | ES2190081T3 (ru) |
FR (1) | FR2763337B1 (ru) |
GT (1) | GT199800068A (ru) |
HR (1) | HRP980258B1 (ru) |
HU (1) | HUP0002763A3 (ru) |
ID (1) | ID22911A (ru) |
IL (1) | IL132903A0 (ru) |
IS (1) | IS5235A (ru) |
NO (1) | NO995513L (ru) |
NZ (1) | NZ500637A (ru) |
PL (1) | PL336772A1 (ru) |
RU (1) | RU2175323C2 (ru) |
SI (1) | SI0984960T1 (ru) |
SK (1) | SK154299A3 (ru) |
TR (1) | TR199902795T2 (ru) |
TW (1) | TW396155B (ru) |
UY (1) | UY24997A1 (ru) |
WO (1) | WO1998051686A1 (ru) |
YU (1) | YU57999A (ru) |
ZA (1) | ZA983997B (ru) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2802530B1 (fr) * | 1999-12-17 | 2002-02-22 | Sanofi Synthelabo | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant |
CA2420727A1 (en) * | 2000-10-26 | 2002-05-02 | Sanofi-Synthelabo | Triazole derivatives and pharmaceutical compositions comprising them |
FR2815963B1 (fr) * | 2000-10-26 | 2003-02-28 | Sanofi Synthelabo | Nouveaux derives du triazole et les compositions pharmaceutiques les contenant |
HUP0004741A2 (hu) * | 2000-11-28 | 2002-12-28 | Sanofi-Synthelabo | Kémiai eljárás tiazolszármazékok előállítására és új intermedier |
JP2005507932A (ja) * | 2001-10-12 | 2005-03-24 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 肥満の処置のためのフェニル置換5−員窒素含有複素環 |
EP1314733A1 (en) * | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indole-2-carboxamides as factor Xa inhibitors |
EP1479677A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | New indole derivatives as factor xa inhibitors |
EP1532980A1 (en) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
GB0403038D0 (en) * | 2004-02-11 | 2004-03-17 | Novartis Ag | Organic compounds |
JP2010516768A (ja) | 2007-01-26 | 2010-05-20 | メルク・シャープ・エンド・ドーム・コーポレイション | コレシストキニン−1レセプターモジュレーターとしての置換アミノピリミジン |
EP2380631A1 (en) * | 2008-07-15 | 2011-10-26 | Novartis AG | Heteroaryl derivatives as DGAT1 inhibitors |
ES2587139T3 (es) * | 2009-06-09 | 2016-10-20 | Actelion Pharmaceuticals Ltd. | Derivados fluorados de aminotriazol |
EP2490659B1 (de) * | 2009-10-22 | 2017-03-01 | Henkel AG & Co. KGaA | Mittel zur temporären verformung keratinhaltiger fasern, enthaltend eine nichtionische, mittels propylenoxid modifizierte stärke und ein chitosan |
CN106928147A (zh) * | 2017-03-14 | 2017-07-07 | 华东师范大学 | 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用 |
CN107271623A (zh) * | 2017-07-27 | 2017-10-20 | 青岛啤酒股份有限公司 | 基于人体饱腹感的啤酒可饮性评价方法 |
KR20220150270A (ko) | 2019-10-07 | 2022-11-10 | 칼리오페, 인크. | Gpr119 효능제 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2701708B1 (fr) * | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
FR2703995B1 (fr) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
-
1997
- 1997-05-13 FR FR9705850A patent/FR2763337B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-06 WO PCT/FR1998/000905 patent/WO1998051686A1/fr not_active Application Discontinuation
- 1998-05-06 DZ DZ980096A patent/DZ2486A1/xx active
- 1998-05-06 RU RU99125773/04A patent/RU2175323C2/ru not_active IP Right Cessation
- 1998-05-06 PL PL98336772A patent/PL336772A1/xx unknown
- 1998-05-06 AT AT98924383T patent/ATE232207T1/de not_active IP Right Cessation
- 1998-05-06 BR BR9811465-4A patent/BR9811465A/pt not_active IP Right Cessation
- 1998-05-06 DK DK98924383T patent/DK0984960T3/da active
- 1998-05-06 AU AU76599/98A patent/AU725530B2/en not_active Ceased
- 1998-05-06 CZ CZ19994006A patent/CZ289484B6/cs not_active IP Right Cessation
- 1998-05-06 EP EP98924383A patent/EP0984960B1/fr not_active Expired - Lifetime
- 1998-05-06 CA CA002289573A patent/CA2289573A1/fr not_active Abandoned
- 1998-05-06 TR TR1999/02795T patent/TR199902795T2/xx unknown
- 1998-05-06 EE EEP199900524A patent/EE9900524A/xx unknown
- 1998-05-06 NZ NZ500637A patent/NZ500637A/xx unknown
- 1998-05-06 SI SI9830372T patent/SI0984960T1/xx unknown
- 1998-05-06 IL IL13290398A patent/IL132903A0/xx unknown
- 1998-05-06 YU YU57999A patent/YU57999A/sh unknown
- 1998-05-06 ES ES98924383T patent/ES2190081T3/es not_active Expired - Lifetime
- 1998-05-06 DE DE69811223T patent/DE69811223T2/de not_active Expired - Fee Related
- 1998-05-06 HU HU0002763A patent/HUP0002763A3/hu unknown
- 1998-05-06 ID IDW991374A patent/ID22911A/id unknown
- 1998-05-06 KR KR1019997010496A patent/KR20010012541A/ko not_active Application Discontinuation
- 1998-05-06 SK SK1542-99A patent/SK154299A3/sk unknown
- 1998-05-06 CO CO98024703A patent/CO4940485A1/es unknown
- 1998-05-06 JP JP54885398A patent/JP2001524980A/ja not_active Ceased
- 1998-05-06 CN CN98807175A patent/CN1263528A/zh active Pending
- 1998-05-11 AR ARP980102152A patent/AR011729A1/es active IP Right Grant
- 1998-05-12 UY UY24997A patent/UY24997A1/es not_active IP Right Cessation
- 1998-05-12 TW TW087107326A patent/TW396155B/zh active
- 1998-05-12 ZA ZA9803997A patent/ZA983997B/xx unknown
- 1998-05-13 HR HR980258A patent/HRP980258B1/xx not_active IP Right Cessation
- 1998-05-20 GT GT199800068A patent/GT199800068A/es unknown
-
1999
- 1999-10-29 IS IS5235A patent/IS5235A/is unknown
- 1999-11-11 NO NO995513A patent/NO995513L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK154299A3 (en) | N-triazolyl-2-indolecarboxamides and their use as cck-a agonists | |
US7514441B2 (en) | Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents | |
RU2126006C1 (ru) | Трициклические диазепиновые антагонисты вазопрессина и антагонисты окситоцина, способ их получения, фармацевтическая композиция, способ лечения | |
AU2006232660B2 (en) | 1H-Pyrazole 4-Carboxylamides, their preparation and their use as 11Beta-hydroxysteroid dehydrogenase | |
TW200413317A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
SK281840B6 (sk) | Acetamidové deriváty, spôsob ich prípravy a farmaceutický prípravok, ktorý ich obsahuje | |
SK65096A3 (en) | A drug | |
LT3520B (en) | Derivatives of 3-amidopyrazole, process for preparing thereof and pharmaceutical composition containing them | |
KR20090014214A (ko) | 바소프레신 수용체 억제제로서의 치환된 아릴이미다졸론 및트리아졸론 | |
US5166151A (en) | 2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof | |
JP2004526790A (ja) | 新規3c(o)r置換10−シクロヘキシルフェニルベンゾイルピロロベンゾジアゼピン;子宮収縮オキシトシン受容体拮抗薬 | |
JP2002518482A (ja) | β−アミロイドペプチド放出および/またはその合成を阻害する化合物 | |
SK281433B6 (sk) | 5-heterocyklo-1,5-benzodiazepínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie | |
US5093346A (en) | Substituted 1,2,4-triazole angiotensin II antagonists | |
JP2007518788A (ja) | バソプレッシンのアンタゴニスト活性を阻害するトリアゾール誘導体 | |
AU780711B2 (en) | Novel branched substituted amino derivatives of 3-amino-1-phenyl-H(1,2,4)triazol, methods for producing them and pharmaceutical compositions containing them | |
JPH08509237A (ja) | ガストリンまたはcck拮抗剤として有用な1,5‐ベンゾジアゼピン類 | |
CA2528496C (en) | Acylated amino acid amidyl pyrazoles and related compounds | |
AU688316B2 (en) | 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity | |
US20040043995A1 (en) | Novel triazole derivatives, process for their preparation and pharmaceutical compositions containing them | |
US5043349A (en) | Substituted pyrrole angiotensin II antagonists | |
JP4137956B2 (ja) | 複素環化合物 | |
CN1898244B (zh) | 作为血管升压素拮抗剂的三唑衍生物 | |
JP2013505914A (ja) | バソプレシンv2受容体アンタゴニストとしての[1,4]−ベンゾジアゼピン | |
JP5297663B2 (ja) | 複素環化合物 |